60
Views
61
CrossRef citations to date
0
Altmetric
Original Article

Pilot Study of Bone Mineral Density in Breast Cancer Patients Treated with Adjuvant Chemotherapy

, , , &
Pages 6-11 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Stephanie L Hines. (2010) Current and emerging treatment strategies for breast cancer-induced bone loss. Breast Cancer: Targets and Therapy 2, pages 71-77.
Read now
Nina H. Bjarnason, Mette Hitz, Niklas R. Jorgensen & Peter Vestergaard. (2008) Adverse bone effects during pharmacological breast cancer therapy. Acta Oncologica 47:4, pages 747-754.
Read now

Articles from other publishers (59)

Sai‐Ching J. Yeung & Robert F. Gagel. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 14 .
Lichen Ji, Wei Zhang, Xugang Zhong, Tingxiao Zhao, Xixi Sun, Senbo Zhu, Yu Tong, Junchao Luo, Youjia Xu, Di Yang, Yao Kang, Jin Wang & Qing Bi. (2022) Osteoporosis, fracture and survival: Application of machine learning in breast cancer prediction models. Frontiers in Oncology 12.
Crossref
Katherine N. Haseltine, Tariq Chukir, Pinar J. Smith, Justin T. Jacob, John P. Bilezikian & Azeez Farooki. (2021) Bone Mineral Density: Clinical Relevance and Quantitative Assessment. Journal of Nuclear Medicine 62:4, pages 446-454.
Crossref
Madeleine B. Hopson, Maika Onishi, Danielle Awad, Donna Buono, Matthew Maurer, Katherine D. Crew, Elizabeth Shane, Dawn L. Hershman & Kevin Kalinsky. (2020) Prospective Study Evaluating Changes in Bone Quality in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy. Clinical Breast Cancer 20:3, pages e327-e333.
Crossref
Béatrice Bouvard, Cyrille B. Confavreux, Karine Briot, Jacques Bonneterre, Catherine Cormier, Bernard Cortet, Jean-Michel Hannoun-Lévi, Christophe Hennequin, Rose-Marie Javier, Pierre Kerbrat, Eric Lespessailles, Anne Lesur, Didier Mayeur, Julien Paccou, Florence Trémollières, Marie-Hélène Vieillard & Françoise Debiais. (2019) Recommandations françaises de stratégies thérapeutiques pour la prévention et le traitement de l’ostéoporose induite par les traitements adjuvants du cancer du sein. Revue du Rhumatisme 86:5, pages 426-437.
Crossref
Béatrice Bouvard, Cyrille B. Confavreux, Karine Briot, Jacques Bonneterre, Catherine Cormier, Bernard Cortet, Jean-Michel Hannoun-Lévi, Christophe Hennequin, Rose-Marie Javier, Pierre Kerbrat, Eric Lespessailles, Anne Lesur, Didier Mayeur, Julien Paccou, Florence Trémollières, Marie-Hélène Vieillard & Françoise Debiais. (2019) French recommendations on strategies for preventing and treating osteoporosis induced by adjuvant breast cancer therapies. Joint Bone Spine 86:5, pages 542-553.
Crossref
Sai‐Ching Jim Yeung & Robert F. Gagel. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 18 .
Rachel Louise O’Donnell, Katherine M. Clement & Richard J. Edmondson. (2016) Hormone replacement therapy after treatment for a gynaecological malignancy. Current Opinion in Obstetrics & Gynecology 28:1, pages 32-41.
Crossref
María Rosa Villar Vicente, Segundo Seclén Santisteban & Antonio Becerra Fernández. 2014. El hueso en las enfermedades endocrinas y nutricionales. El hueso en las enfermedades endocrinas y nutricionales 169 191 .
Matthias Kalder & Peyman Hadji. 2014. Knochenmetastasen. Knochenmetastasen 139 165 .
Vijayashree Murthy & Ronald S. Chamberlain. (2017) Menopausal Symptoms in Young Survivors of Breast Cancer: A Growing Problem without an Ideal Solution. Cancer Control 19:4, pages 317-329.
Crossref
P. Hadji, M. Gnant, J.J. Body, N.J. Bundred, A. Brufsky, R.E. Coleman, T.A. Guise, A. Lipton & M.S. Aapro. (2012) Cancer treatment-induced bone loss in premenopausal women: A need for therapeutic intervention?. Cancer Treatment Reviews 38:6, pages 798-806.
Crossref
Madhusmita Misra. (2012) Effects of hypogonadism on bone metabolism in female adolescents and young adults. Nature Reviews Endocrinology 8:7, pages 395-404.
Crossref
Jeong Eun Kim, Jin-Hee Ahn, Kyung Hae Jung, Sung-Bae Kim, Hwa Jung Kim, Keun-Suk Lee, Jung-Sil Ro, Yun-Hee Park, Jin-Suk Ahn, Young-Hyk Im, Seock-Ah Im, Moon-Hee Lee & Si-Young Kim. (2010) Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSG-BR06-01). Breast Cancer Research and Treatment 125:1, pages 99-106.
Crossref
Kouji Izumi, Atsushi Mizokami, Kazuhiro Sugimoto, Kazutaka Narimoto, Sotaro Miwa, Yuji Maeda, Yoshifumi Kadono, Mitsuhiro Takashima, Eitetsu Koh & Mikio Namiki. (2009) Risedronate Recovers Bone Loss in Patients With Prostate Cancer Undergoing Androgen-deprivation Therapy. Urology 73:6, pages 1342-1346.
Crossref
Stephanie L. HinesBetty Anne MinceyJeff A. SloanSachdev P. ThomasElaine ChottinerCharles L. LoprinziMark D. CarlsonPamela J. AthertonMuhammad SalimEdith A. Perez. (2009) Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast Cancer. Journal of Clinical Oncology 27:7, pages 1047-1053.
Crossref
Fred SaadJonathan D. AdachiJacques P. BrownLeah A. CanningKaren A. GelmonRobert G. JosseKathleen I. Pritchard. (2008) Cancer Treatment–Induced Bone Loss in Breast and Prostate Cancer. Journal of Clinical Oncology 26:33, pages 5465-5476.
Crossref
Dawn L. Hershman, Donald J. McMahon, Katherine D. Crew, Serge Cremers, Dinaz Irani, Gina Cucchiara, Lois Brafman & Elizabeth Shane. (2008) Zoledronic Acid Prevents Bone Loss in Premenopausal Women Undergoing Adjuvant Chemotherapy for Early-Stage Breast Cancer. Journal of Clinical Oncology 26:29, pages 4739-4745.
Crossref
Peter Vestergaard. (2007) Adverse Effects of Drugs on Bone and Calcium Metabolism/Physiology. Clinical Reviews in Bone and Mineral Metabolism 6:1-2, pages 1-16.
Crossref
Adi Cohen, Jessica B. Fleischer, Mariko K. Johnson, Ijeoma N. Brown, Andrew K. Joe, Dawn L. Hershman, Donald J. McMahon & Shonni J. Silverberg. (2008) Prevention of Bone Loss After Withdrawal of Tamoxifen. Endocrine Practice 14:2, pages 162-167.
Crossref
David M. Reid, Julie Doughty, Richard Eastell, Steven D. Heys, Anthony Howell, Eugene V. McCloskey, Trevor Powles, Peter Selby & Robert E. Coleman. (2008) Guidance for the management of breast cancer treatment-induced bone loss: A consensus position statement from a UK Expert Group. Cancer Treatment Reviews 34, pages S3-S18.
Crossref
AILLEEN HERAS-HERZIG, WENDE M. KOZLOW, SUE A. BROWN & THERESA A. GUISE. 2008. Osteoporosis. Osteoporosis 1337 1374 .
Mimi I. Hu, Robert F. Gagel & Camilo Jimenez. (2009) Bone loss in patients with breast or prostate cancer. Current Osteoporosis Reports 5:4, pages 170-178.
Crossref
José Manuel Olmos Martínez & Jesús González Macías. (2007) Osteoporosis tras la curación tumoral. Medicina Clínica 129:17, pages 669-676.
Crossref
Carolyn Ingram & Constance Visovsky. (2007) Exercise Intervention to Modify Physiologic Risk Factors in Cancer Survivors. Seminars in Oncology Nursing 23:4, pages 275-284.
Crossref
Hongliu Ding & Terry S. Field. (2007) Bone health in postmenopausal women with early breast cancer: How protective is tamoxifen?. Cancer Treatment Reviews 33:6, pages 506-513.
Crossref
Jianmin Chen, Krista A. Power, Jaskaren Mann, Astor Cheng & Lilian U. Thompson. (2016) Flaxseed Alone or in Combination with Tamoxifen Inhibits MCF-7 Breast Tumor Growth in Ovariectomized Athymic Mice with High Circulating Levels of Estrogen. Experimental Biology and Medicine 232:8, pages 1071-1080.
Crossref
Karen Basen-Engquist & Diane C. Bodurka. 2007. Cancer Survivorship. Cancer Survivorship 114 121 .
Angela Hirbe, Elizabeth A. Morgan, Özge Uluçkan & Katherine Weilbaecher. (2006) Skeletal Complications of Breast Cancer Therapies. Clinical Cancer Research 12:20, pages 6309s-6314s.
Crossref
Janice J. Twiss, Gloria J. Gross, Nancy L. Waltman, Carol D. Ott & Ada M. Lindsey. (2006) Health behaviors in breast cancer survivors experiencing bone loss. Journal of the American Academy of Nurse Practitioners 18:10, pages 471-481.
Crossref
Betty A. Mincey, Mei Sheng Duh, Simu K. Thomas, Erick Moyneur, Maryna Marynchencko, Simone Peart Boyce, David Mallett & Edith A. Perez. (2006) Risk of Cancer Treatment—Associated Bone Loss and Fractures Among Women with Breast Cancer Receiving Aromatase Inhibitors. Clinical Breast Cancer 7:2, pages 127-132.
Crossref
Carolyn Ingram, Kerry S. Courneya & Dawn Kingston. (2006) The Effects of Exercise on Body Weight and Composition in Breast Cancer Survivors: An Integrative Systematic Review. Oncology Nursing Forum 33:5, pages 937-950.
Crossref
Karen Basen-Engquist & Diane C. Bodurka. 2006. Oncology. Oncology 1838 1845 .
Kimberly Templeton. (2005) Secondary Osteoporosis. Journal of the American Academy of Orthopaedic Surgeons 13:7, pages 475-486.
Crossref
Luz-Milva Rodríguez-Rodríguez, Eva-María Rodríguez-Rodríguez, Juana-María Oramas-Rodríguez, Francisco Santolaria-Fernandez, Marta Llanos, Josefina Cruz, Antonio Martínez, Emilio González-Reimers, Angeles Gómez & Norberto Batista. (2005) Changes on Bone Mineral Density after Adjuvant Treatment in Women with Non-metastatic Breast Cancer. Breast Cancer Research and Treatment 93:1, pages 75-83.
Crossref
Elena B. Elkin, Milton C. Weinstein, Karen M. Kuntz, Craig A. Bunnell & Jane C. Weeks. (2005) Adjuvant Ovarian Suppression Versus Chemotherapy for Premenopausal, Hormone-responsive Breast Cancer: Quality of Life and Efficacy Tradeoffs. Breast Cancer Research and Treatment 93:1, pages 25-34.
Crossref
Karen K. Swenson, Susan J. Henly, Alice C. Shapiro & Lynne M. Schroeder. (2005) Interventions to Prevent Loss of Bone Mineral Density in Women Receiving Chemotherapy for Breast Cancer. Clinical Journal of Oncology Nursing 9:2, pages 177-184.
Crossref
Julian R Molina, Debra L Barton & Charles L Loprinzi. (2005) Chemotherapy-Induced Ovarian Failure. Drug Safety 28:5, pages 401-416.
Crossref
Cynthia A. Thomson, Zhao Chen & Robert B. Lutz. 2005. Fundamentals of Cancer Prevention. Fundamentals of Cancer Prevention 25 59 .
C. Crandall, L. Petersen, P. A. Ganz & G. A. Greendale. (2004) Bone mineral density and adjuvant therapy in breast cancer survivors. Breast Cancer Research and Treatment 88:3, pages 257-261.
Crossref
Á. Sverrisdóttir, T. Fornander, H. Jacobsson, E. von Schoultz & L.E. Rutqvist. (2004) Bone Mineral Density Among Premenopausal Women With Early Breast Cancer in a Randomized Trial of Adjuvant Endocrine Therapy. Journal of Clinical Oncology 22:18, pages 3694-3699.
Crossref
Betty A. Mincey & Winston W. Tan. (2004) The Management of Bone Loss in Patients with Breast or Prostate Cancer. Supportive Cancer Therapy 1:3, pages 150-156.
Crossref
DAWN HERSHMAN, ELLEN RITCHIE & ZACHARY ROSNER. 2004. Principles of Gender-Specific Medicine. Principles of Gender-Specific Medicine 637 647 .
Bhuvaneswari Ramaswamy & Charles L Shapiro. (2003) Osteopenia and osteoporosis in women with breast cancer. Seminars in Oncology 30:6, pages 763-775.
Crossref
Edwin Rock & Angela DeMichele. (2003) Nutritional Approaches to Late Toxicities of Adjuvant Chemotherapy in Breast Cancer Survivors. The Journal of Nutrition 133:11, pages 3785S-3793S.
Crossref
Nancy L. Waltman, Janice J. Twiss, Carol D. Ott, Gloria Jean Gross, Ada M. Lindsey, Timothy E. Moore & Kris Berg. (2004) Testing an Intervention for Preventing Osteoporosis in Postmenopausal Breast Cancer Survivors. Journal of Nursing Scholarship 35:4, pages 333-338.
Crossref
Nancy C Greep, Armando E Giuliano, Nora M Hansen, Tami Taketani, He-Jing Wang & Frederick R Singer. (2003) The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer. The American Journal of Medicine 114:8, pages 653-659.
Crossref
DA Hanley, JP Brown, A Tenenhouse, WP Olszynski, G Ioannidis, C Berger, JC Prior, L Pickard, TM Murray, T Anastassiades, S Kirkland, C Joyce, L Joseph, A Papaioannou, SA Jackson, S Poliquin & JD Adachi. (2003) Associations Among Disease Conditions, Bone Mineral Density, and Prevalent Vertebral Deformities in Men and Women 50 Years of Age and Older: Cross-Sectional Results From the Canadian Multicentre Osteoporosis Study. Journal of Bone and Mineral Research 18:4, pages 784-790.
Crossref
Betty A. Mincey. (2003) Osteoporosis in women with breast cancer. Current Oncology Reports 5:1, pages 53-57.
Crossref
Robert E. Coleman. (2003) Current and future status of adjuvant therapy for breast cancer. Cancer 97:S3, pages 880-886.
Crossref
Janet E. Brown & Robert E. Coleman. (2002) Assessment of the effects of breast cancer on bone and the response to therapy. The Breast 11:5, pages 375-385.
Crossref
Ada M. Lindsey, Gloria Gross, Jan Twiss, Nancy Waltman, Carol Ott & Timothy E. Moore. (2002) Postmenopausal Survivors of Breast Cancer at Risk for Osteoporosis: Nutritional Intake and Body Size. Cancer Nursing 25:1, pages 50-56.
Crossref
Gloria Jean Gross, Carol D. Ott, Ada M. Lindsey, Janice J. Twiss & Nancy Waltman. (2002) Postmenopausal Breast Cancer Survivors at Risk for Osteoporosis: Physical Activity, Vigor, and Vitality. Oncology Nursing Forum 29:9, pages 1295-1300.
Crossref
A.Y. Rostom. (2001) The Management of Menopausal Sequelae in Patients with Breast Cancer. Clinical Oncology 13:3, pages 174-180.
Crossref
Suzanne M. Mahon, Melanie T. Williams & Martha A. Spies. (2008) Screening for Second Cancers and Osteoporosis in Long‐Term Survivors. Cancer Practice 8:6, pages 282-290.
Crossref
Suzanne M. Mahon, Melanie T. Williams & Martha A. Spies. (2000) Screening for Second Cancers and Osteoporosis in Long-Term Survivors. Cancer Practice 8:6, pages 282-290.
Crossref
Betty A. Mincey, Thomas J. Moraghan & Edith A. Perez. (2000) Prevention and Treatment of Osteoporosis in Women With Breast Cancer. Mayo Clinic Proceedings 75:8, pages 821-829.
Crossref
CHERI L. KUTYNEC, LINDA McCARGAR, SUSAN I. BARR & T.GREGORY HISLOP. (1999) Energy Balance in Women With Breast During Adjuvant Treatment. Journal of the American Dietetic Association 99:10, pages 1222-1227.
Crossref
Lichen Ji, Wei Zhang, Xugang Zhong, Tingxiao Zhao, Xixi Sun, Senbo Zhu, Yu Tong, Junchao Luo, Youjia Xu, Di Yang, Yao Kang, Jin Wang & Qing Bi. (2022) Osteoporosis, Fracture and Survival: Application of Machine Learning in Breast Cancer Prediction Models. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.